Cell-penetrating peptides for drug delivery across membrane barriers
- PMID: 18095931
- DOI: 10.1517/17425247.5.1.105
Cell-penetrating peptides for drug delivery across membrane barriers
Abstract
During the last decade, cell-penetrating peptides have been investigated for their ability to overcome the plasma membrane barrier of mammalian cells for the intracellular or transcellular delivery of cargoes as diverse as low molecular weight drugs, imaging agents, oligonucleotides, peptides, proteins and colloidal carriers such as liposomes and polymeric nanoparticles. Their ability to cross biological membranes in a non-disruptive way without apparent toxicity is highly desired for increasing drug bioavailability. This review provides an overview of the application of cell-penetrating peptides as transmembrane drug delivery agents, according to the recent literature, and discusses critical issues and future challenges in relation to fully understanding the fundamental principles of the cell-penetrating peptide-mediated membrane translocation of cargoes and the exploitation of their therapeutic potential.
Similar articles
-
Chances and pitfalls of cell penetrating peptides for cellular drug delivery.Eur J Pharm Biopharm. 2004 Sep;58(2):209-23. doi: 10.1016/j.ejpb.2004.02.018. Eur J Pharm Biopharm. 2004. PMID: 15296950 Review.
-
Targeted intracellular delivery of therapeutics: an overview.Pharmazie. 2007 Sep;62(9):643-58. Pharmazie. 2007. PMID: 17944316 Review.
-
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):548-58. doi: 10.1016/j.addr.2007.10.008. Epub 2007 Nov 28. Adv Drug Deliv Rev. 2008. PMID: 18053612 Review.
-
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.Curr Opin Pharmacol. 2006 Oct;6(5):509-14. doi: 10.1016/j.coph.2006.04.004. Epub 2006 Jul 24. Curr Opin Pharmacol. 2006. PMID: 16860608 Review.
-
The performance of nanocarriers for transmucosal drug delivery.Expert Opin Drug Deliv. 2006 Jul;3(4):463-78. doi: 10.1517/17425247.3.4.463. Expert Opin Drug Deliv. 2006. PMID: 16822222 Review.
Cited by
-
Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology.Commun Biol. 2021 Feb 15;4(1):205. doi: 10.1038/s42003-021-01726-w. Commun Biol. 2021. PMID: 33589718 Free PMC article.
-
Progress toward therapy with antisense-mediated splicing modulation.Curr Opin Mol Ther. 2009 Apr;11(2):116-23. Curr Opin Mol Ther. 2009. PMID: 19330717 Free PMC article. Review.
-
Chemically modified peptides and proteins - critical considerations for oral delivery.Tissue Barriers. 2016 Mar 3;4(2):e1156805. doi: 10.1080/21688370.2016.1156805. eCollection 2016 Apr-Jun. Tissue Barriers. 2016. PMID: 27358754 Free PMC article. Review.
-
Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets.Front Cell Neurosci. 2019 Nov 27;13:528. doi: 10.3389/fncel.2019.00528. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31827423 Free PMC article. Review.
-
Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530. Curr Drug Targets. 2024. PMID: 39313872 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical